IL-33 may ameliorate D-gal–induced aging bone loss and memory impairment in mice by regulating IL-17, Tregs, BACE1 expression, and tau phosphorylation, thereby inhibiting inflammaging. The gene discussed is IL33; the disease is memory impairment.